These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 31210712)

  • 21. Current management of hepatocellular carcinoma.
    Tabrizian P; Roayaie S; Schwartz ME
    World J Gastroenterol; 2014 Aug; 20(30):10223-37. PubMed ID: 25132740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the treatment of hepatocellular carcinoma on the waiting list necessary?
    Majno P; Lencioni R; Mornex F; Girard N; Poon RT; Cherqui D
    Liver Transpl; 2011 Oct; 17 Suppl 2():S98-108. PubMed ID: 21954097
    [No Abstract]   [Full Text] [Related]  

  • 23. Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?
    Yao FY; Breitenstein S; Broelsch CE; Dufour JF; Sherman M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S109-16. PubMed ID: 21584927
    [No Abstract]   [Full Text] [Related]  

  • 24. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma: Ablate and wait versus rapid transplantation.
    Roberts JP; Venook A; Kerlan R; Yao F
    Liver Transpl; 2010 Aug; 16(8):925-9. PubMed ID: 20658555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: Where do we stand with tumor down-staging?
    Yao FY; Fidelman N
    Hepatology; 2016 Mar; 63(3):1014-25. PubMed ID: 26560491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma.
    Samuel D; Colombo M; El-Serag H; Sobesky R; Heaton N
    Liver Transpl; 2011 Oct; 17 Suppl 2():S6-13. PubMed ID: 21858912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of hepatocellular carcinoma grade by needle biopsy is unreliable for liver transplant candidate selection.
    Court CM; Harlander-Locke MP; Markovic D; French SW; Naini BV; Lu DS; Raman SS; Kaldas FM; Zarrinpar A; Farmer DG; Finn RS; Sadeghi S; Tomlinson JS; Busuttil RW; Agopian VG
    Liver Transpl; 2017 Sep; 23(9):1123-1132. PubMed ID: 28688158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma.
    Park SJ; Freise CE; Hirose R; Kerlan RK; Yao FY; Roberts JP; Vagefi PA
    Clin Transplant; 2012; 26(4):E359-64. PubMed ID: 22693962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current approach to down-staging of hepatocellular carcinoma prior to liver transplantation.
    Hanje AJ; Yao FY
    Curr Opin Organ Transplant; 2008 Jun; 13(3):234-40. PubMed ID: 18685309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation.
    Kim PT; Onaca N; Chinnakotla S; Davis GL; Jennings LW; McKenna GJ; Ruiz RM; Levy MF; Goldstein R; Klintmalm GB
    Clin Transplant; 2013; 27(2):311-8. PubMed ID: 23351129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy.
    Cucchetti A; Cescon M; Bigonzi E; Piscaglia F; Golfieri R; Ercolani G; Cristina Morelli M; Ravaioli M; Daniele Pinna A
    Liver Transpl; 2011 Nov; 17(11):1344-54. PubMed ID: 21837731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in and challenges regarding the surgical treatment of hepatocellular carcinoma in China.
    Liu D; Song T
    Biosci Trends; 2021 Jul; 15(3):142-147. PubMed ID: 33716267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Operative therapy of hepatocellular carcinoma].
    Farkas SA; Schlitt HJ
    Radiologe; 2014 Jul; 54(7):673-8. PubMed ID: 25047523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indications and limitations of liver transplantation for hepatocellular carcinoma.
    Wudel LJ; Chapman WC
    Surg Oncol Clin N Am; 2003 Jan; 12(1):77-90, ix. PubMed ID: 12735131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver transplantation beyond or downstaging within the Milan criteria for hepatocellular carcinoma.
    Rudnick SR; Russo MW
    Expert Rev Gastroenterol Hepatol; 2018 Mar; 12(3):265-275. PubMed ID: 29231769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria.
    Herrero JI; Sangro B; Pardo F; Quiroga J; Iñarrairaegui M; Rotellar F; Montiel C; Alegre F; Prieto J
    Liver Transpl; 2008 Mar; 14(3):272-8. PubMed ID: 18306328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanded Criteria for Hepatocellular Carcinoma in Liver Transplant.
    Haberal M; Akdur A; Moray G; Arslan G; Özçay F; Selçuk H; Özdemir H
    Exp Clin Transplant; 2017 Mar; 15(Suppl 2):55-58. PubMed ID: 28302000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria.
    Yao FY
    Am J Transplant; 2008 Oct; 8(10):1982-9. PubMed ID: 18727702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor Diameter for Hepatocellular Carcinoma: Why Should Size Matter?
    Usta S; Kayaalp C
    J Gastrointest Cancer; 2020 Dec; 51(4):1114-1117. PubMed ID: 32851543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.